TWIST interacts with endothelin-1/endothelin A receptor signaling in osteosarcoma cell survival against cisplatin

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 857-861

  Zhou, Yong ^a   Zang, Xiaofang ^a   Huang, Zufa ^a   Zhang, Chaoyue ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cell survival; Cisplatin; Endothelin A receptor; Endothelin 1; Osteosarcoma; TWIST

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CISPLATIN; CYCLO (DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; MESSENGER RNA; PROTEIN KINASE B; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NICK END LABELING; OSTEOSARCOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84872691828     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1111     Document Type: Article

References (21)

1. Ottaviani G and Jaffe N: The epidemiology of osteosarcoma. Cancer Treat Res 152: 3-13, 2010.
2. Chou AJ and Gorlick R: Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer Ther 6: 1075-1085, 2006.
3. Entz-Werlé N, Lavaux T, Metzger N, et al: Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis. Neoplasia 9: 678-688, 2007.
4. Stoetzel C, Weber B, Bourgeois P, Bolcato-Bellemin AL and Perrin-Schmitt F: Dorso-ventral and rostro-caudal sequential expression of M-twist in the postimplantation murine embryo. Mech Dev 51: 251-263, 1995.
5. El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, et al: Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15: 42-46, 1997.
6. Entz-Werlé N, Choquet P, Neuville A, et al: Targeted apc;twist double-mutant mice: a new model of spontaneous osteosarcoma that mimics the human disease. Transl Oncol 3: 344-353, 2010.
7. Le Deley MC, Guinebretière J, Gentet JC, et al: SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Eur J Cancer 43: 752-761, 2007.
8. Nelson J, Bagnato A, Battistini B and Nisen P: The endothelin axis: emerging role in cancer. Nat Rev Cancer 3: 110-116, 2003.
9. Felx M, Guyot MC, Felx M, Guyot MC, Isler M, TurcotteRE, Doyon J, Khatib AM, Leclerc S, Moreau A and Moldovan F: Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin Sci (Lond) 110: 645-654, 2006.
10. Zhao Y, Liao Q, Zhu Y and Long H: Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis. Clin Orthop Relat Res 469: 3190-3199, 2011.
11. Matsuo N, Shiraha H, Fujikawa T, et al: Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 9: 240, 2009.
12. Okamura H, Yoshida K and Haneji T: Negative regulation of TIMP1 is mediated by transcription factor TWIST1. Int J Oncol 35: 181-186, 2009.
13. Funato N, Ohtani K, Ohyama K, Kuroda T and Nakamura M: Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Mol Cell Biol 21: 7416-7428, 2001.
14. Guenou H, Kaabeche K, Dufour C, Miraoui H and MariePJ: Down-regulation of ubiquitin ligase Cbl induced by twist haploinsufficiency in Saethre-Chotzen syndrome results in increased PI3K/Akt signaling and osteoblast proliferation. Am J Pathol 169: 1303-1311, 2006.
15. Kim YJ, Koo TY, Yang WS, Han NJ, Jeong JU, Lee SK and ParkSK: Activation of spleen tyrosine kinase is required for TNF-α-induced endothelin-1 upregulation in human aortic endothelial cells. FEBS Lett 586: 818-826, 2012.
16. Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT and Wong YC: Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 23: 474-482, 2004.
17. Sun P, Xiong H, Kim TH, Ren B and Zhang Z: Positive inter-regulation between β-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Mol Pharmacol 69: 520-531, 2006.
18. Zhao Y, Liao Q, Zhu Y and Long H: Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis. Clin Orthop Relat Res 469: 3190-3199, 2011.
19. Wu MH, Lo JF, Kuo CH, et al: Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways. J Cell Physiol 227: 3016-3026, 2012.
20. Kulasekaran P, Scavone CA, Rogers DS, Arenberg DA, Thannickal VJ and Horowitz JC: Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. Am J Respir Cell Mol Biol 41: 484-493, 2009.
21. Rosenberg B, Vancamp L, Trosko JE and Mansour VH: Platinum Compounds: a new class of potent antitumour agents. Nature 222: 385-386, 1969.